Search results
Results from the WOW.Com Content Network
The Alcohol Use Disorders Identification Test (AUDIT) is a ten-item questionnaire approved by the World Health Organization to screen patients for hazardous (risky) and harmful alcohol consumption. It was developed from a WHO multi-country collaborative study, [ 1 ] [ 2 ] [ 3 ] the items being selected for the AUDIT being the best performing of ...
Alcohol education is the planned provision of information and skills relevant to living in a world where alcohol is commonly misused. [4] WHO Global Status Report on Alcohol and Health, highlights the fact that alcohol will be a larger problem in later years, with estimates suggesting it will be the leading cause of disability and death.
Benzodiazepines have the largest and the best evidence base in the treatment of alcohol withdrawal and are considered the gold standard of alcohol detoxification. [27] Pharmacological treatments for alcohol addiction include drugs like naltrexone (opioid antagonist), disulfiram, acamprosate, and topiramate.
The risk of death in suicide attempts involving overdose is about 2%. [72] [verification needed] Most people are under the influence of sedative-hypnotic drugs (such as alcohol or benzodiazepines) when they die by suicide, [73] with alcoholism present in between 15% and 61% of cases. [74]
Male veterans with drug or alcohol addictions from the Philadelphia VA Medical Center have been recruited for the establishment of ASI. [1] [2]The Addiction Severity Index (ASI) is used to assess the severity of patient's addiction and analyse the need of treatment which has been in use for more than 2 decades since its publication in 1992.
Not all medications have a fixed relationship on this scale. Methadone is different from most opioids because its potency can vary depending on how long it is taken. Acute use (1–3 days) yields a potency about 1.5× stronger than that of morphine and chronic use (7 days+) yields a potency about 2.5 to 5× that of morphine.
"Pain ladder", or analgesic ladder, was created by the World Health Organization (WHO) as a guideline for the use of drugs in the management of pain. Originally published in 1986 for the management of cancer pain , it is now widely used by medical professionals for the management of all types of pain .
In other words, the perceived benefits must outweigh the perceived barriers in order for behavior change to occur. [1] [14] Perceived barriers to taking action include the perceived inconvenience, expense, danger (e.g., side effects of a medical procedure) and discomfort (e.g., pain, emotional upset) involved in engaging in the behavior. [2]